WebJul 2, 2024 · The new FSRH guideline addresses the contraceptive needs of this important group. Key recommendations include: For women with body mass index (BMI) 35kg/m2 or greater, the potential risks associated with use of combined hormonal contraception (CHC) generally outweigh the benefits. WebThe guideline was produced by the Faculty of Sexual and Reproductive Healthcare (FSRH) Clinical Effectiveness Unit in collaboration with the RCOG. The management of women who present with unscheduled bleeding while using hormonal contraception is challenging.
FSRH Guideline (April 2024) Overweight, Obesity and …
WebApr 1, 2024 · This new document aims to summarise the available evidence on contraceptive choices for women who are overweight and women with obesity (i.e. with body mass index 25 kg/m2 or higher). This guideline evaluates the interrelationship … WebObesity and Etonogestrel implant use The etonogestrel implant is a safe and effective method of contraception for people who have a raised body mass index (BMI).(1, 2) The effect of obesity on contraceptive steroid metabolism and pharmacokinetics is poorly understood.(3) There are limited data addressing use in those with a BMI ≥30 kg/m2. rs3 rsh
CLINICAL PRACTICE GUIDELINE Contraception
WebFor women with obesity (BMI categories of >=30-34 kg/m2 and >=35 kg/m2) without coexistent medical conditions the UKMEC categorises all progestogen-only contraceptives and intrauterine contraception as UKMEC 1, which means that there are no restrictions on the use of these methods. WebFaculty of Sexual and Reproductive Healthcare of the Royal College of Obestricians and Gynaecologists (UK), Current clinical guidance on contraceptives, www.fsrh.org/standards-and-guidance/current-clinical-guidance World Health Organization Medical eligibility criteria (5th edn), www.who.int/reproductivehealth/publications/family_planning/MEC-5/en WebFSRH Clinical Guideline: Contraceptive Choices for Young People (March 2010, amended May 2024) ... Obesity and Contraception 2024. 1 May 2024 Documents... The grading information is included in Appendix 1. 4 Individual/FSRH Member Vii Summary section POP Clinical recommendation Currently states ‘Double dose POP is not recommended for … rs3 rowdy unruly